Matthew J. Harms Bioscience Metabolism, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D AstraZeneca Biography Publications Institution JoVE Articles Matthew J. Harms has not added a biography. If you are Matthew J. Harms and would like to personalize this page please email our Author Liaison for assistance. Publications Liposomal Delivery of PPARα/γ Dual Agonist Tesaglitazar in a Model of Obesity Enriches Macrophage Targeting and Limits Liver and Kidney Drug Effects Theranostics. 2020 | Pubmed ID: 31903139 Mature Human White Adipocytes Cultured Under Membranes Maintain Identity, Function, and Can Transdifferentiate into Brown-like Adipocytes Cell Reports. 04, 2019 | Pubmed ID: 30943403 Flow Cytometry of Mouse and Human Adipocytes for the Analysis of Browning and Cellular Heterogeneity Cell Reports. 09, 2018 | Pubmed ID: 30184507 膜成熟性アディポサイト凝集培養(MAAC)を用いたヒト成熟性の単離と培養 Ida Alexandersson1, Matthew J. Harms1, Jeremie Boucher1,2,3 1Bioscience Metabolism, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, 2The Lundberg Laboratory for Diabetes Research, University of Gothenburg, 3Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg JoVE 60485 Biology
膜成熟性アディポサイト凝集培養(MAAC)を用いたヒト成熟性の単離と培養 Ida Alexandersson1, Matthew J. Harms1, Jeremie Boucher1,2,3 1Bioscience Metabolism, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, 2The Lundberg Laboratory for Diabetes Research, University of Gothenburg, 3Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg JoVE 60485 Biology
